Incidence and management of high grade glioma in Māori and non-Māori patients

Hamish Alexander, Chris Irwin, Gordon Purdie, Martin Hunn

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)


A retrospective analysis of 301 patients was undertaken between 1993 and 2003 to evaluate the relationship of ethnicity with incidence, treatment and survival in patients undergoing surgery for high grade glioma (HGG) in New Zealand. There was no difference in age standardised incidence of HGG in Mori compared to non-Mori patients; 4.2/100,000 person years (95% confidence interval [CI] 2.6-6.9) versus 4.1 (95% CI 3.6-4.6). Mori were more likely to have complete tumour resection (odds ratio 3.59 (95% CI 1.01-12.76)) but waited 1.32 (95% CI 0.98-1.79) times longer for radiotherapy. Median survival was 29 weeks with poorer survival in Mori compared to non-Mori (hazard ratio 1.55 [95% CI 0.95-2.55]). We concluded that the incidence of HGG in Mori is similar to non-Maori. However, Mori with HGG have higher rates of complete resection but wait longer for radiotherapy and may have poorer overall survival than non-Mori.

Original languageEnglish
Pages (from-to)1144-1147
Number of pages4
JournalJournal of Clinical Neuroscience
Issue number9
Publication statusPublished - Sep 2010
Externally publishedYes


  • Astrocytoma
  • Glioblastoma multiforme
  • Glioma
  • Mori

Cite this